Sort
16,300 grants matching “fatty liver disease”
Activation of C/EBP-β by mitohormesis as a therapy for obesity
$148,251Alessandro Bitto · University Of Washington · K01 · FY2022 · DK
Identification of Biomarkers and Novel Pathways of Alcoholic Liver Disease by Leveraging Metabolomics, Tissue Imaging Mass Spectrometry, and Integrative Machine Learning
$148,243Vasilis Vasiliou · Yale University · R21 · FY2021 · AA
Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism
$148,186Robert Nathaniel Helsley · University Of Kentucky · K01 · FY2025 · DK
Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism
$148,186Robert Nathaniel Helsley · University Of Kentucky · K01 · FY2024 · DK
Pennington/Louisiana NORC - Admin Supplement for Pilot and Feasibility studies 2021
$148,000Eric Ravussin · Lsu Pennington Biomedical Research Ctr · P30 · FY2021 · DK
Research Translation Core: Extending the Reach of Exposure Science and Technology That Improves the Detection and Remediation of Hazardous Substances
$147,963Keith Pezzoli · University Of California, San Diego · P42 · FY2021 · ES
Community Engagement and Urban Agriculture: Addressing Concerns About Toxicants in Soil, Water and Plants
$147,961Keith Pezzoli · University Of California, San Diego · P42 · FY2021 · ES
Clinical Research Network in Non Alcoholic Steatohepati*
$147,933University Of Washington · U01 · FY2004 · DK
Niemann-Pick C liver-specific proteostasis and pathology
$147,917Mark Louis Schultz · University Of Iowa · K01 · FY2023 · DK
Combined Use of Exercise and Metformin for Metabolic Rehabilitation
$147,667Barry Steven Braun · University Of Massachusetts Amherst · R56 · FY2008 · DK
RECOMBINANT LEPTIN THERAPY FOR TREATMENT OF NASH
$147,592Elif Arioglu Oral · University Of Michigan At Ann Arbor · R03 · FY2007 · DK
Fenofibrate for the treatment of patients with NASH
$147,592Hari S Conjeevaram · University Of Michigan At Ann Arbor · R03 · FY2007 · DK
Cntnap2 in diet-induced obesity
$147,528David A Buchner · University Of Michigan At Ann Arbor · K01 · FY2011 · DK
Cntnap2 in diet-induced obesity
$147,528David A Buchner · University Of Michigan At Ann Arbor · K01 · FY2012 · DK
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
$147,500Deborah Ann Fraser · California State University Long Beach · R16 · FY2025 · GM
Complement Protein C1q Regulation of Macrophage Metabolic Pathways
$147,500Deborah Ann Fraser · California State University Long Beach · R16 · FY2024 · GM
Chromium treatment of Obesity-related insulin resistance
$147,495Dennis C Mynarcik · State University New York Stony Brook · R21 · FY2008 · AT
A novel, orally available small molecule AMPK activator as a treatment for non al
$147,371John M Kyriakis · Mercury Therapeutics. Inc. · R43 · FY2014 · DK
Role of Arginase in Diabetic Nephropathy
$147,321Alaa S Awad · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · DK
SREBP-Mediated Lipid Regulation in the Intestine
$147,246Luke James Engelking · Ut Southwestern Medical Center · K08 · FY2015 · DK
SREBP-Mediated Lipid Regulation in the Intestine
$147,246Luke James Engelking · Ut Southwestern Medical Center · K08 · FY2014 · DK
SREBP-Mediated Lipid Regulation in the Intestine
$147,246Luke James Engelking · Ut Southwestern Medical Center · K08 · FY2016 · DK
Cntnap2 in diet-induced obesity
$147,042David A Buchner · University Of Michigan At Ann Arbor · K01 · FY2010 · DK
Melanocortin-3 receptor regulation of insulin action
$147,000Lsu Pennington Biomedical Research Ctr · R21 · FY2004 · DK
Melanocortin-3 receptor regulation of insulin action
$147,000Lsu Pennington Biomedical Research Ctr · R21 · FY2005 · DK